F092 - Granulomatous Disorders of the Adult Skin
Sunday, February 18; 1:00 PM - 3:00 PM
Following this course, the attendee should be able to:
- Differentiate the Non-infectious granulomatous diseases (NIGD) and Infectious granulomatous diseases (IGD) of adult skin.
- Recognize the cutaneous clinical, histological and systemic manifestations of NIGD and IGD.
- Determine the best evidence based therapeutic modalities for the treatment of NIGD and IGD.
Granulomatous disorders represent a unique group of diseases, both noninfectious and infectious, that require the utmost clinical pathologic correlation combined with a keen sense of inquiry for underlying systemic disease and immunosuppression.
Dermatologists need to be able to differentiate these entities, evaluate patients for specific underlying systemic disease (i.e. from diabetes to cancer), and treat them with a wide range of immunosuppressant to anti-infectious medications.
By being aware of the skin manifestations of these abnormal physiologic responses dermatologists can improve patient safety, outcome and health care costs.
- English, Joseph C. III, MD: no financial relationships exist with commercial interests.
- Rosenbach, Misha, MD: Derm101 – Independent Contractor(H); Endocyte – I(NC); Gilead Sciences, Inc – I(Grants/Research Funding); GlaxoSmithKline – C(NC); Merck & Co., Inc – A(H); Promet Therapeutics, LLC – C(H);